| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004017996A1 Arthrodial cartilage extracellular matrix degradation inhibitor |
| 03/04/2004 | WO2004017974A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 03/04/2004 | WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases |
| 03/04/2004 | WO2004017908A2 Calcium receptor modulating compound and use thereof |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2003080104A3 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 03/04/2004 | WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003054018A3 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 03/04/2004 | WO2003051365A3 Use of compounds of the benzamide family as immunosuppressant |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002083075A3 Akt and regulation of ra synovial fibroblast apoptosis |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044013 Antiarthritic agents; side effect reduction |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040044001 Use of II-1 inhibitors for treating II-1 mediated diseases |
| 03/04/2004 | US20040044000 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders |
| 03/04/2004 | US20040043979 Antiarthritic agents; cardiovascular disorders; imflammatory bowel disorders; skin disordfers; vision disorders |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/04/2004 | US20040043966 Using 1-hydroxy-2-(imidazolo(1,2-a)pyridin-3-yl)ethanediphosphonic acid; bone disorders |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043072 Alleviation of upper gastrointestinal irritation |
| 03/04/2004 | US20040043018 Adjust concentration of interleukins |
| 03/04/2004 | US20040043008 Dissociation muscle tissues; culturing; accumulation |
| 03/04/2004 | US20040043007 Transfection system |
| 03/04/2004 | DE10238477A1 Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel New purine derivatives, their preparation and their use as medicaments |
| 03/04/2004 | DE10238169A1 Verfahren zur vereinfachten Herstellung einer Zusammensetzung mit hohem Avarolgehalt mit verbesserter Wirkung sowie dessen Verwendung zur Behandlung proliferativer Funktionsstörungen oder zur Herstellung von reinem Avarol und Avaron hieraus A process for the simplified preparation of a composition with a high Avarolgehalt having improved activity and the use thereof for treating proliferative disorders or for preparing pure avarol and avarone thereof |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496234A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | CA2496211A1 New purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 03/04/2004 | CA2495597A1 Novel phenanthridines |
| 03/04/2004 | CA2495354A1 An agent for inhibiting articular cartilage extracellular matrix degradation |
| 03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | CA2494634A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 03/03/2004 | EP1393075A2 Methods of screening and using inhibitors of angiogenesis |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392823A2 Desaturase genes and uses thereof |
| 03/03/2004 | EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 03/03/2004 | EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392681A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
| 03/03/2004 | EP1392666A1 Biologically active methylene blue derivatives |
| 03/03/2004 | EP1392664A1 Epothilone derivatives |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392657A2 Protease inhibitors |
| 03/03/2004 | EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 03/03/2004 | EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 03/03/2004 | EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 03/03/2004 | EP1392349A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 03/03/2004 | EP1392338A1 Herbal drug composition for cartilage protection |
| 03/03/2004 | EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 03/03/2004 | EP1392325A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 03/03/2004 | EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392299A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 03/03/2004 | EP1392275A1 Use of protein and essential amino acids to treat amenorrhea and related disorders |
| 03/03/2004 | EP1392272A1 Permeation enhancers |
| 03/03/2004 | EP1392247A2 Process for preparing granular compositions |
| 03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
| 03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 03/03/2004 | EP1124797B1 N-arylsulfonyl amino acid omega amides |
| 03/03/2004 | EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP0998460B1 Novel tetrazole derivatives |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |